Major MNCs Set Sights On Persian Gulf's Forecast Diabetes Growth
This article was originally published in PharmAsia News
Executive Summary
The wealthy nations of the Persian Gulf and their adaptations of Western lifestyles have made them a diabetes target by global drug makers, some already creating partnerships with local makers, including for production plants.